Targeted panel testing superior for neuromuscular diseases

Targeted panel testing superior for neuromuscular diseases

(HealthDay)—Targeted panel testing has the highest clinical yield for molecular diagnosis of neuromuscular diseases (NMDs), according to a study published in the February issue of the Annals of Neurology.

Arunkanth Ankala, Ph.D., from the Emory University School of Medicine in Atlanta, and colleagues designed and validated several next generation sequencing (NGS)-based comprehensive gene panel tests. The validation established that the targeted gene panel tests have 100 percent sensitivity and specificity for detection of single nucleotide variants. The clinical diagnostic yields of single gene tests were compared with NMD NGS panels using data from all clinical tests performed at the Emory Genetic Laboratory. The clinical utility of the targeted NGS panel test was also compared with that of .

The researchers found that the diagnostic yield was three-fold higher for the NMD comprehensive panel testing than for single gene testing (46 versus 15 to 19 percent). Panel testing was complemented by Sanger fill-in of low coverage exons, copy number variation analysis, and thorough in-house validation of the assay, allowing detection of all types of causative pathogenic variants, of which about 18 percent may be missed by exome sequencing.

"Our results strongly indicate that for of heterogeneous disorders such as NMDs, targeted panel testing has the highest clinical yield and should therefore be the preferred first-tier approach," the authors write.


Explore further

Panel-based genetic diagnostic testing for inherited eye disease proves highly accurate

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Annals of Neurology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Targeted panel testing superior for neuromuscular diseases (2015, February 13) retrieved 24 July 2019 from https://medicalxpress.com/news/2015-02-panel-superior-neuromuscular-diseases.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more